Article

Immunological findings in a group of individuals who were non-responders to standard two-dose SARS-CoV-2 vaccines

2022-05-06

Abstract excerpt

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic. The virus has infected more than 505 million people and caused more than 6 million deaths. However, data on non-responders to SARS-CoV-2 vaccines in the general population are limited. The objective of the study is to comprehensively compare the immunological characteristics of non-respo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2a08d904-f5af-5d32-a402-1a760a76f21b
DOI: 10.1101/2022.05.05.490815

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunological findings in a group of individuals who were non-responders to standard two-dose SARS-CoV-2 vaccinesDOI 10.1101/2022.05.05.490815Read

Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalizationSemantic proximity Read

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19Semantic proximity Read

Cohort Profile: The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)Semantic proximity Read

Observational Report on Functional SARS-CoV-2 Immune Responses in Immune Competent and Compromised IndividualsSemantic proximity Read

Changes of Humoral Immunity Response in SARS-CoV-2 Convalescent Patients over 8 monthsSemantic proximity Read

Differences in the concentration of anti-SARS-CoV-2 IgG antibodies post-COVID-19 recovery or post-vaccinationSemantic proximity Read

Cellular immune response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity Read

Correlates of protection against SARS-CoV-2 shedding in a controlled human infection study in immune-experienced participantsSemantic proximity Read

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patientsSemantic proximity Read

Cellular and Humoral Responses to SARS-CoV-2 Vaccination in Immunosuppressed PatientsSemantic proximity Read

Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow upSemantic proximity Read

Vaccination Induces Stronger Spike Immunity and Better Protection Against SARS-CoV-2 Infection in COVID-19 Recovered Subjects than in Naïve IndividualsSemantic proximity Read